文献速递关节外科

自报镍过敏与无镍过敏患者全膝关节置换术后临床结果的比较:匹配与非匹配队列对比

A Comparison of Clinical Outcomes After Total Knee Arthroplasty in Patients Who Have and Do Not Have Self-Reported Nickel Allergy: Matched and Unmatched Cohort Comparisons.
PubMed 文献 · J Arthroplasty · 2024-05-15

该研究比较了284例自报镍过敏与17,735例无自报镍过敏的全膝关节置换术(TKA)患者的翻修率和患者报告结局。结果显示,两组1年无全因翻修生存率相似,镍过敏组在6周和1年时KOOS JR、VAS、LEAS评分无差异,但6周时PROMIS心理和身体评分略差;按假体类型分层匹配分析后,6周和1年KOOS JR评分无差异。

要点

  • 自报镍过敏患者TKA术后1年无全因翻修生存率与无过敏患者相似(99.5% vs 99.3%,P=0.49)。
  • 两组在6周和1年时KOOS JR、VAS、LEAS评分无差异,但镍过敏组6周时PROMIS心理和身体评分略差。
  • 按假体类型(无镍 vs 标准钴铬)分层匹配分析后,6周和1年KOOS JR评分无差异(P=0.113和P=0.415)。

核心结论

  • 自报镍过敏患者可被告知,其临床结局评分平均改善程度与无自报镍过敏患者相似,翻修率也相似。

研究设计与样本

  • 在5年期间,共实施284例自报镍过敏患者的TKA和17,735例无自报镍过敏患者的TKA。
  • 比较两组翻修率及术前和术后患者报告结局指标,包括KOOS JR、VAS、LEAS和PROMIS心理和身体评分。

主要发现

  • 1年无全因翻修生存率:自报镍过敏组99.5%(95% CI 98.6-100.0) vs 无自报镍过敏组99.3%(95% CI 99.1-99.4),P=0.49。
  • 自报镍过敏组在6周和1年时KOOS JR、VAS和LEAS评分无差异,6周时PROMIS心理和身体评分略差。
  • 匹配分析显示,按假体类型(无镍 vs 标准钴铬)分层后,两组6周和1年KOOS JR评分无差异(P=0.113和P=0.415)。

临床怎么用

  • 作者结论指出,自报镍过敏患者可被告知临床结局评分平均改善程度与无过敏患者相似,翻修率也相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of a preoperative self-reported nickel allergy in patients undergoing primary total knee arthroplasty (TKA) remains unclear. The aim of this study was to compare the revision rates and outcomes of patients who have a self-reported nickel allergy undergoing primary TKA to patients who do not have a self-reported nickel allergy. METHODS: Over 5 years, a total of 284 TKAs in patients who have and 17,735 in patients who do not have a self-reported nickel allergy were performed. Revision rates and differences in preoperative and postoperative patient-reported outcome measures, including Knee Osteoarthritis Outcome Score Joint Replacement (KOOS JR), Visual Analog Scale, Lower Extremity Activity Scale, and the Patient-Reported Outcomes Measurement Information System Mental and Physical Scores, were compared. RESULTS: Survivorship free of all-cause revision at 1 year was similar for patients who have and do not have a self-reported nickel allergy (99.5% [95% CI (confidence interval): 98.6 to 100.0] versus 99.3% [95% CI: 99.1 to 99.4]), P = .49). Patients who have a self-reported nickel allergy undergoing primary TKA had no difference in KOOS JR, Visual Analog Scale, or Lower Extremity Activity Scale scores at 6 weeks and 1 year and slightly worse Patient-Reported Outcomes Measurement Information System mental and physical scores at 6 weeks compared to patients who did not have an allergy. Matched analysis revealed no difference in 6-week or 1-year KOOS, JR scores between patients who did and did not have a self-reported nickel allergy when stratified by implant class (nickel-free versus standard cobalt-chromium) (P = .113 and P = .415, respectively). CONCLUSIONS: Patients who have a self-reported nickel allergy can be advised that, on average, their clinical outcome scores will improve similarly to patients who do not have a self-reported nickel allergy, and revision rates will be similar.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Siljander BR, Chandi SK, Cororaton AD, et al. A Comparison of Clinical Outcomes After Total Knee Arthroplasty in Patients Who Have and Do Not Have Self-Reported Nickel Allergy: Matched and Unmatched Cohort Comparisons. J Arthroplasty. 2024. PMID: 38759819. doi:10.1016/j.arth.2024.05.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。